Parents

Sign in to add mentor
David Scott Pederson grad student 2003 University of Vermont
 (The role of Clf1 in the assembly and activation of replication intitation complexes in budding yeast.)
Anindya Dutta post-doc 2007 UVA
Melvin L. DePamphilis post-doc 2009 NIH
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhang Y, Li J, Zhou Y, et al. (2022) And-1 coordinates with the FANCM complex to regulate Fanconi Anemia signaling and cisplatin resistance. Cancer Research
Li J, Zhang Y, Sun J, et al. (2021) Discovery and characterization of potent And-1 inhibitors for cancer treatment. Clinical and Translational Medicine. 11: e627
Hu Z, Mi S, Zhao T, et al. (2020) BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. The Embo Journal. e104133
Zhang Y, Wu X, Kai Y, et al. (2019) Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancer. Jci Insight. 4
Zhang Y, Li Z, Hao Q, et al. (2019) The Cdk2-c-Myc-miR-571 Axis Regulates DNA Replication and Genomic Stability by Targeting Geminin. Cancer Research
Dai S, Yang S, Hu X, et al. (2019) 17-hydroxy wortmannin restores TRAIL's response by ameliorating increased beclin 1 level and autophagy function in TRAIL-resistant colon cancer cells. Molecular Cancer Therapeutics
Peng Y, Liao Q, Tan W, et al. (2019) The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitors. Nature Communications. 10: 1224
Chen CW, Li Y, Hu S, et al. (2018) DHS (trans-4,4'-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2). Oncogene
Tian T, Wang M, Zhu Y, et al. (2018) Expression, Clinical Significance, and Functional Prediction of MNX1 in Breast Cancer. Molecular Therapy. Nucleic Acids. 13: 399-406
Sun J, Cai X, Yung MM, et al. (2018) miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer. Oncogene
See more...